Brain metastases as preventive and therapeutic targets (Q37862581)

24 August 2017

1 reference

title

Brain metastases as preventive and therapeutic targets (English)

1 reference

24 August 2017

1 reference

1

Patricia S Steeg

1 reference

24 August 2017

Kevin A Camphausen

2

1 reference

PubMed ID

21472002

24 August 2017

Quentin R Smith

series ordinal

3

1 reference

PubMed ID

21472002

24 August 2017

language of work or name

English

0 references

publication date

7 April 2011

1 reference

24 August 2017

Nature Reviews Cancer

1 reference

24 August 2017

11

1 reference

24 August 2017

5

1 reference

24 August 2017

352-363

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc3053

24 August 2017

0 references

cites work

Medical management of brain metastases from lung cancer (Review).

1 reference

Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases.

21 January 2018

1 reference

CNS metastases in breast cancer

21 January 2018

1 reference

Brain metastases: the HER2 paradigm

21 January 2018

1 reference

Breast cancer metastasis to the central nervous system

21 January 2018

1 reference

Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.

21 January 2018

1 reference

Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases

21 January 2018

1 reference

Central nervous system metastasis from breast carcinoma. Autopsy study.

21 January 2018

1 reference

Melanoma-induced brain metastases

21 January 2018

1 reference

Development of a chemoresistant orthotopic human nonsmall cell lung carcinoma model in nude mice: analyses of tumor heterogenity in relation to the immunohistochemical levels of expression of cyclooxygenase-2, ornithine decarboxylase, lung-related r

21 January 2018

1 reference

Real-time imaging reveals the single steps of brain metastasis formation

21 January 2018

1 reference

A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro

21 January 2018

1 reference

Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer

21 January 2018

1 reference

Pazopanib reveals a role for tumor cell B-Raf in the prevention of HER2+ breast cancer brain metastasis

21 January 2018

1 reference

Genes that mediate breast cancer metastasis to the brain

21 January 2018

1 reference

Brain metastasis model in athymic nude mice using a novel MUC1-secreting human breast-cancer cell line, MA11.

21 January 2018

1 reference

The vascular basement membrane as "soil" in brain metastasis

21 January 2018

1 reference

Antiangiogenic therapy of cerebral melanoma metastases results in sustained tumor progression via vessel co-option

21 January 2018

1 reference

Rodent models of brain metastasis in melanoma

21 January 2018

1 reference

Transforming growth factor-beta2 is a molecular determinant for site-specific melanoma metastasis in the brain

21 January 2018

1 reference

Molecular basis for the critical role of suppressor of cytokine signaling-1 in melanoma brain metastasis

21 January 2018

1 reference

Noninvasive imaging of the functional effects of anti-VEGF therapy on tumor cell extravasation and regional blood volume in an experimental brain metastasis model

21 January 2018

1 reference

Host TIMP-1 overexpression confers resistance to experimental brain metastasis of a fibrosarcoma cell line

21 January 2018

1 reference

Reduction of brain metastases in plasminogen activator inhibitor-1-deficient mice with transgenic ocular tumors

21 January 2018

1 reference

Development of a preclinical model of spontaneous human melanoma central nervous system metastasis

21 January 2018

1 reference

Reactive glia are recruited by highly proliferative brain metastases of breast cancer and promote tumor cell colonization

21 January 2018

1 reference

Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis.

21 January 2018

1 reference

Hematogenous metastases of the human brain--characteristics of peritumoral brain changes: a review

21 January 2018

1 reference

Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis

21 January 2018

1 reference

Reactive astrocytes protect melanoma cells from chemotherapy by sequestering intracellular calcium through gap junction communication channels

21 January 2018

1 reference

Immunoexpression of endoglin in brain metastasis secondary to malignant melanoma: evaluation of angiogenesis and comparison with brain metastasis secondary to breast and lung carcinomas.

21 January 2018

1 reference

Vascular endothelial growth factor-A determines detectability of experimental melanoma brain metastasis in GD-DTPA-enhanced MRI.

21 January 2018

1 reference

Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice

21 January 2018

1 reference

In vivo magnetic resonance imaging of single cells in mouse brain with optical validation

21 January 2018

1 reference

HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer

21 January 2018

1 reference

HER family receptor abnormalities in lung cancer brain metastases and corresponding primary tumors

21 January 2018

1 reference

EGFR and HER-2 status of non-small cell lung cancer brain metastasis and corresponding primary tumor.

21 January 2018

1 reference

Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer

21 January 2018

1 reference

O(6)-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancers

21 January 2018

1 reference

Differential expression of biomarkers in primary non-small cell lung cancer and metastatic sites.

21 January 2018

1 reference

Very high frequency of hypermethylated genes in breast cancer metastasis to the bone, brain, and lung

21 January 2018

1 reference

Genome remodelling in a basal-like breast cancer metastasis and xenograft

21 January 2018

1 reference

Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases

21 January 2018

1 reference

Reduced mRNA and protein expression of BCL-2 versus decreased mRNA and increased protein expression of BAX in breast cancer brain metastases: a real-time PCR and immunohistochemical evaluation.

21 January 2018

1 reference

Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis

21 January 2018

1 reference

Activation of stat3 in human melanoma promotes brain metastasis.

21 January 2018

1 reference

Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain

21 January 2018

1 reference

Co-overexpression of Met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells

21 January 2018

1 reference

WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis

21 January 2018

1 reference

MicroRNA-1258 suppresses breast cancer brain metastasis by targeting heparanase

21 January 2018

1 reference

Response of brain metastases from breast cancer to systemic chemotherapy

21 January 2018

1 reference

Chemotherapy induces regression of brain metastases in breast carcinoma.

21 January 2018

1 reference

Topotecan chemotherapy in patients with breast cancer and brain metastases: results of a pilot study.

21 January 2018

1 reference

Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer

21 January 2018

1 reference

Temozolomide for the treatment of metastatic melanoma

21 January 2018

1 reference

Capecitabine therapy of central nervous system metastases from breast cancer.

21 January 2018

1 reference

Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma.

21 January 2018

1 reference

The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline

21 January 2018

1 reference

Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial

21 January 2018

1 reference

Gefitinib as palliative therapy for lung adenocarcinoma metastatic to the brain.

21 January 2018

1 reference

A case of radiation recall pneumonitis induced by erlotinib, which can be related to high plasma concentration

21 January 2018

1 reference

High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib

21 January 2018

1 reference

Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized trials

21 January 2018

1 reference

Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood-brain barrier.

21 January 2018

1 reference

The role of efflux and uptake transporters in [N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine (GW572016, lapatinib) disposition and drug interactions.

21 January 2018

1 reference

Distribution of tamoxifen and metabolites into brain tissue and brain metastases in breast cancer patients

21 January 2018

1 reference

Safety of bevacizumab in patients with non-small-cell lung cancer and brain metastases

21 January 2018

1 reference

Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America

21 January 2018

1 reference

Medicinal chemical properties of successful central nervous system drugs

21 January 2018

1 reference

Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development

21 January 2018

1 reference

Targeting multidrug resistance in cancer

21 January 2018

1 reference

Functions of the breast cancer resistance protein (BCRP/ABCG2) in chemotherapy.

21 January 2018

1 reference

Breast cancer resistance protein and P-glycoprotein limit sorafenib brain accumulation

21 January 2018

1 reference

Distribution of gefitinib to the brain is limited by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)-mediated active efflux

21 January 2018

1 reference

Pericytes regulate the blood-brain barrier

21 January 2018

1 reference

Pericytes are required for blood-brain barrier integrity during embryogenesis

21 January 2018

1 reference

Maintaining blood-brain barrier integrity: pericytes perform better than astrocytes during prolonged oxygen deprivation.

21 January 2018

1 reference

Vorinostat inhibits brain metastatic colonization in a model of triple-negative breast cancer and induces DNA double-strand breaks

21 January 2018

1 reference

A phase II trial of vorinostat (suberoylanilide hydroxamic acid) in metastatic breast cancer: a California Cancer Consortium study

21 January 2018

1 reference

Carboplatin and Paclitaxel in combination with either vorinostat or placebo for first-line therapy of advanced non-small-cell lung cancer

21 January 2018

1 reference

Vorinostat enhances the radiosensitivity of a breast cancer brain metastatic cell line grown in vitro and as intracranial xenografts

21 January 2018

1 reference

Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain

21 January 2018

1 reference

Cellular and in vivo activity of JNJ-28871063, a nonquinazoline pan-ErbB kinase inhibitor that crosses the blood-brain barrier and displays efficacy against intracranial tumors

21 January 2018

1 reference

A novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cells

21 January 2018

1 reference

Sagopilone crosses the blood-brain barrier in vivo to inhibit brain tumor growth and metastases

21 January 2018

1 reference

Systemic vesicular stomatitis virus selectively destroys multifocal glioma and metastatic carcinoma in brain.

21 January 2018

1 reference

Reovirus as an experimental therapeutic for brain and leptomeningeal metastases from breast cancer

21 January 2018

1 reference

Incidence of brain metastases in renal cell carcinoma treated with sorafenib

21 January 2018

1 reference

A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses

21 January 2018

1 reference

Development of central nervous system metastases in patients with advanced non-small cell lung cancer and somatic EGFR mutations treated with gefitinib or erlotinib

21 January 2018

1 reference

The expression of three genes in primary non-small cell lung cancer is associated with metastatic spread to the brain.

21 January 2018

1 reference

Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer

21 January 2018

1 reference

Uptake of ANG1005, a novel paclitaxel derivative, through the blood-brain barrier into brain and experimental brain metastases of breast cancer

21 January 2018

1 reference

Phosphodiesterase type 5 inhibitors increase Herceptin transport and treatment efficacy in mouse metastatic brain tumor models

21 January 2018

1 reference

Effects of fractionated radiation on the brain vasculature in a murine model: blood-brain barrier permeability, astrocyte proliferation, and ultrastructural changes.

21 January 2018

1 reference

Chemotherapy delivery issues in central nervous system malignancy: a reality check.

21 January 2018

1 reference

Radiation sensitization with redox modulators: a promising approach

21 January 2018

1 reference

Motexafin gadolinium: a novel radiosensitizer for brain tumors.

21 January 2018

1 reference

In vitro and in vivo radiosensitization of glioblastoma cells by the poly (ADP-ribose) polymerase inhibitor E7016.

21 January 2018

1 reference

Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair.

21 January 2018

1 reference

Targeting polo-like kinase 1 enhances radiation efficacy for head-and-neck squamous cell carcinoma

21 January 2018

1 reference

In vitro and in vivo radiosensitization with AZD6244 (ARRY-142886), an inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 kinase

21 January 2018

1 reference

Orthotopic growth of human glioma cells quantitatively and qualitatively influences radiation-induced changes in gene expression

21 January 2018

1 reference

Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial

21 January 2018

1 reference

Inflammation and chronic oxidative stress in radiation-induced late normal tissue injury: therapeutic implications

21 January 2018

1 reference

Irradiation-induced progenitor cell death in the developing brain is resistant to erythropoietin treatment and caspase inhibition

21 January 2018

1 reference

Cell-density-dependent regulation of neural precursor cell function.

21 January 2018

1 reference

An animal model of prophylactic cranial irradiation: histologic effects at acute, early and delayed stages

21 January 2018

1 reference

Inflammatory Blockade Restores Adult Hippocampal Neurogenesis

21 January 2018

1 reference

Aging-dependent changes in the radiation response of the adult rat brain.

21 January 2018

1 reference

Whole-brain radiotherapy in the management of brain metastasis

21 January 2018

1 reference

The AT1 receptor antagonist, L-158,809, prevents or ameliorates fractionated whole-brain irradiation-induced cognitive impairment

21 January 2018

1 reference

Adding pioglitazone to insulin containing regimens in type 2 diabetes: systematic review and meta-analysis

21 January 2018

1 reference

Effect of fibrates on lipid profiles and cardiovascular outcomes: a systematic review

21 January 2018

1 reference

Administration of the peroxisomal proliferator-activated receptor gamma agonist pioglitazone during fractionated brain irradiation prevents radiation-induced cognitive impairment.

21 January 2018

1 reference

The PPARalpha agonist fenofibrate preserves hippocampal neurogenesis and inhibits microglial activation after whole-brain irradiation

21 January 2018

1 reference

High-throughput screening identifies two classes of antibiotics as radioprotectors: tetracyclines and fluoroquinolones.

21 January 2018

1 reference

21 January 2018

Neoplastic meningitis

1 reference

Leptomeningeal metastasis: survival and prognostic factors in 155 patients

21 January 2018

1 reference

Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: Final results of the first two studies by the radiation therapy oncology group

21 January 2018

1 reference

The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline

21 January 2018

1 reference

Prophylactic cranial irradiation in extensive small-cell lung cancer

21 January 2018

1 reference

Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non-small-cell lung cancer: a Cochrane Review.

21 January 2018

1 reference

Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method.

21 January 2018

1 reference

Cancer. What does radiotherapy do to endothelial cells?

21 January 2018

1 reference

Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival

21 January 2018

1 reference

An experimental model of brain metastasis of lung carcinoma

31 March 2020

1 reference

Microglia promote colonization of brain tissue by breast cancer cells in a Wnt-dependent way.

31 March 2020

1 reference

Combination therapy with platinum and etoposide of brain metastases from breast carcinoma

31 March 2020

1 reference

Cerebrospinal fluid concentration of erlotinib and its active metabolite OSI-420 in patients with central nervous system metastases of non-small cell lung cancer

31 March 2020

1 reference

Quantitative magnetic resonance spectroscopy reveals a potential relationship between radiation-induced changes in rat brain metabolites and cognitive impairment

31 March 2020

1 reference

Leptomeningeal tissue: a barrier against brain tumor cell invasion

31 March 2020

1 reference

Leptomeningeal metastases

31 March 2020

1 reference

The palliation of brain metastases: Final results of the first two studies by the radiation therapy oncology group

31 March 2020

1 reference

Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases

31 March 2020

1 reference

Survival and pattern of failure in brain metastasis treated with stereotactic gamma knife radiosurgery

31 March 2020

1 reference

12 December 2020

Differential Notch and TGFbeta signaling in primary colorectal tumors and their corresponding metastases.

1 reference

12 December 2020

Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice

1 reference

12 December 2020

The distribution of secondary growths in cancer of the breast. 1889

1 reference

12 December 2020

Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRC3053

1 reference

24 August 2017

0 references

1 reference

PubMed ID

21472002